T1	Participants 24 159	serotonin-migraine with 1,3,4,14b-tetrahydro-2,7-dimethyl-2H-dibenzo(b,f)pyrazino-(1,2--d)-(1,4)-oxazepine hydrogen maleate (Org GC 94)
T2	Participants 654 769	treatment with 3 x 5 mg/day of Org GC 94 for a period of 3 months can almost completely eliminate migraine attacks.
T3	Participants 770 797	21 out of 30 patients (70%)
T4	Participants 971 1014	30 patients receiving 3 x 0.5 mg or placebo
